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Behcet’s disease is a chronic multisystem vasculitis of unknown aetiology. This case report describes a patient 
who applied to the hospital because of dyspnoea, ascites, oedema of lower extremities and recurrent episodes 
of haemoptysis. For the last 12 yr, he had superior vena cava syndrome (SVCS) and cardiac and pulmonary 
involvement of Behcet’s disease, and biochemical examination of ascite fluid yielded a chylous effusion 
containing triglyceride 421 mg dl - ’ and cholesterol 49 mg dl- ‘. Chyloptysis was also detected by Sudan III 
stain. The patient died from cardiac tamponade in spite of cardiac fenestration. To the authors’ knowledge, 
this is the first reported case of Behcet’s disease with chylous ascites and chyloptysis in the English literature. 
Introduction 
Behcet’s disease is a multisystem vasculitis which 
was first described in 1937 by a Turkish derma- 
tologist named Hulusi Behcet. In the distribution 
of the old Silk Route from Asia across the 
Mediterranean into Europe (l), Behcet’s disease is 
most often observed in Turkey. This case report 
describes a patient with Behcet’s disease who had 
pulmonary and cardiac involvement, and superior 
vena cava syndrome (SVCS) for 12 yr. In addition, he 
had chylous ascites and chyloptysis. 
Case Report 
A 40-year-old man with a history of Behcet’s 
disease since 1982 was admitted to the Department of 
Chest Diseases of Dokuz Eyliil University Hospital, 
Turkey, because of chest pain, dyspnoea, cough, 
abdominal distention and lower extremity oedema. 
He was first diagnosed as having Behcet’s disease 
because of recurrent oral and genital ulcerations, eye 
involvement and positive Pathergy test. Colchicin 
1.5 g daily had been given until cardiac (pericarditis) 
and vascular involvement [superior vena cava syn- 
drome (SVCS)] developed and then oral prednisolone 
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8 mg daily was added to the treatment. In 1989, 
right hydropneumothorax developed and chest tube 
thoracostomy was applied. Since then, he had been 
doing well on colchicine 1 g day- ’ and prednisolone 
8mgday-‘. He was admitted to Dokuz Eyliil 
University Hospital in 1994 with chest pain, 
dyspnoea and abdominal distention. On physical 
examination, the patient was frail and appeared 
chronically ill. There was marked oedema over the 
neck, shoulders and lower extremities. The abdomen 
was distended and non-tender; a fluid wave and 
shifting dullness were present. The liver was palpable 
6 cm below the costal margin, the spleen was not felt 
and no masses were palpated. The urine was normal. 
The haematocrit was 43%, the white cell count was 
12 900, and the platelet count was 304 000. Erythro- 
cyte sedimentation rate was 13mmh-‘. The 
prothrombin time was 13.4 s and the activated 
partial thromboplastin time was 42 s. The blood 
urea nitrogen was 29 mg ml - ‘, and creatinine was 
1.0 mg dl- ‘. The potassium was 4.8 mm01 I- ‘, AST 
was 89 IU 1 - ’ and ALT was 59 IU l- i. Serum total 
protein was 5.4 g dl - ’ and serum albumin was 
2.9 g dl- ‘. All other biochemical tests were within 
normal limits. An electrocardiogram disclosed a 
normal rhythm at a rate of 74 bpm and low voltage in 
all leads was noted. An X-ray film of the chest 
showed bilateral pleural effusion, right pleural thick- 
ening and cardiomegaly. A computed tomographic 
(CT) scan of the thorax showed mediastinal shift to 
the right, bilateral pleural thickening, and pericardial 
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effusion. In addition to massive calcification at the 
proximal part of the main pulmonary artery, many 
abnormalities in the venous vascular structures were 
noted. The filling defect seen in the superior vena 
cava was thought to be due to a thrombus. Azygos 
and hemiazygos veins were dilated. Due to venous 
stasis, contrast material in the right thoracic wall and 
axillary veins were not blushed away. No evidence 
of lymphadenopathy was found in this region. 
Abdomen CT showed massive ascites, and distended 
and dilated inferior vena cava. The liver, spleen 
and kidneys were within normal limits. Magnetic 
resonance imaging (MRI) of the thorax revealed 
bilateral pleural effusion and segmental atelectasis on 
the lower lobe of the right lung, and increased signal 
intensity in the azygos and hemiazygos veins due 
to decreased Bow. Magnetic resonance imaging 
examination of the abdomen showed massive ascites. 
Inferior vena cava was dilated but no evidence of 
stasis was noted. Portal and splenic veins were 
patent, no evidence of an intraluminal mass or 
thrombus was observed. The liver, spleen and kidney 
had normal architecture and signal intensity. 
Doppler ultrasound revealed normal flow and cali- 
bration of vena porta, vena splenica and vena 
hepatica, but revealed calcified thrombus in right and 
left jugular vena and total flow occlusion in the left 
subclavian vena. 
An abdominal paracentesis yielded milky white 
fluid that contained 7 cells mn-- 3 of which 100% 
were lymphocytes. The triglyceride content of the 
fluid was 421 mgdl-‘, cholesterol 26 mg dl - ‘, glu- 
cose 133 mg dl- i, protein 0.5 g dl- ‘, amylase 
35 U 1~ ’ and LDH was 48 U l- ‘. Microscopical 
examination and culture of the fluid showed no fungi, 
acid-fast bacilli, or other micro-organisms. Cytologic 
examination of the fluid revealed a predominance of 
mesothelial cells. Sudan III stain revealed fat globules 
in fluid. 
The patient was treated with 40 mg prednisolone 
and 80 mg furosemide daily. His complaints 
decreased and physical examination revealed im- 
provement. The patient was discharged and called for 
the follow-up period. One month later, he presented 
with pericardial tamponade because of massive peri- 
cardial efft+sion, bilateral pleural effusions and mas- 
sive ascites. Sputum and ascites fluid had a milky 
appearance. Chyloptosis was confirmed by Sudan III 
stain. Massive pericardial and pleural fluids had 
sero-haemorrhagic biochemical analysis. Pericardial 
fenestration and pleural tube thoracostomy were 
made because of hypotension. Anuria and shock 
progressed despite medical support and the patient 
died. Pericardial mononuclear cell infiltration and 
hepatic periportal fibrosis were detected by post- 
mortem needle biopsies. His family did not give 
permission for autopsy. 
Discussion 
Pulmonary involvement in Behcet’s disease is not 
usual. The prevalence is reported to be around 5% by 
Raz et al. In Turkey, studies have reported 92,34,32, 
20, 15 and nine cases with pulmonary involvement 
(24). To the authors’ knowledge, this is the first 
reported case of Behcet’s disease with chylous ascites 
and chyloptysis in the English literature. 
Chylothorax is much more common than chylous 
ascites, although both are rare. In 50% of cases, 
chylothorax is related to a tumour (5). Normally, 
chylomicrons are absorbed from the gastrointestinal 
tract, enter the intestinal lacteal vessels, empty into 
the cistema chyli which overlies the body of the 
second lumbar vertebra, and then drain into the 
thoracic duct across the oesophageal hiatus into 
the thoracic vein cavity on the right side in an extra- 
pleural location until the level of T4 or T6, where it 
crosses the mediastinum and then empties into the 
left subclavian vein. 
Chylous ascites is rarer. In 30% of cases, it is due to 
a neoplasm; in 35% of cases, it is due to inflamma- 
tion; in 11% of cases, it is due to trauma; in 1% of 
cases, it is due to congenital causes; and in 23% of 
cases it is idiopathic. In a recent report, neoplastic 
disease was the cause of chylous ascites in 87% of 
cases. Lymphomas constitute about half of these; the 
other half is caused by a variety of primary and 
metastatic neoplasms. The inflammatory causes of 
chylous ascites are quite varied, including tuberculo- 
sis, pancreatitis, portal vein thrombosis, mesenteric 
adenitis, adhesions with intestinal obstruction, radia- 
tion and pulmonary fibrosis. With thoracic duct 
obstruction, chylous ascites may also be seen rarely in 
uncomplicated cirrhosis (6). In the present case, CT 
and MRI did not show any intra-abdominal or 
intrathoracic masses which compressed or infiltrated 
the duct. Chylous ascites in this patient may have 
developed due to a mechanism similar to that of 
other inflammatory causes. In this patient, SVCS 
may have caused retrograde stasis in the ductus 
thoracicus and may have contributed to development 
of chylous ascites, although, in the authors’ opinion, 
this alone should not be wholly responsible, because 
the retrograde pressure transmitted by the SVCS may 
increase the pressure in the ductus thoracicus, mainly 
immediately before it empties into the venous system. 
If any rupture was present at this level, chylothorax 
would have accompanied the chylous ascites. 
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This patient had multiple organ involvement of 
Behcet’s disease such as vascular [SVCS and inferior 
vena cava syndrome (IVCS)], pulmonary (bilateral 
pleural effusions, history of pneumothorax), cardiac 
(pericarditis) and eye (decolman of the vitreus) 
involvements and chylous ascites and chyloptysis. 
The authors suggest that Behcet’s disease should be 
considered in the differential diagnosis of chylous 
ascites. 
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